Radioimmunoscintigraphy with In-111-labeled capromab pendetide predicts prostate cancer response to salvage radiotherapy after failed radical prostatectomy

Journal of Clinical Oncology

Volumn 16, Issue 1, 1998, Pages 284-289

  Kahn, Daniel ^a   Williams, Richard D ^a   Haseman, Michael K ^a   Reed, Nancy L ^a   Miller, Sara J ^a   Gerstbrein, Jack ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPROMAB; CAPROMAB PENDETIDE; CAPROMAB PENDETIDE IN 111; INDIUM 111; MONOCLONAL ANTIBODY; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; HUMAN; IMMUNOSCINTIGRAPHY; MALE; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CARCINOMA; PROSTATECTOMY; TREATMENT FAILURE;

EID: 0031962155     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.1.284     Document Type: Article

References (13)

1. Takayama TK, Lange PH: Radiation therapy for local recurrence of prostate cancer after radical prostatectomy. Urol Clin North Am 21:687-700, 1994
2. Kahn D, Williams RD, Seldin DW, et al: Radioimmunoscintigraphy with In 111-labeled CYT-356 for the detection of occult prostate cancer recurrence. J Urol 152:1490-1495, 1994
3. Haseman MK, Reed NL, Rosenthal SA: Antibody imaging of occult disease in patients with elevated PSA following definitive treatment for prostate cancer: PET and biopsy correlation. Clin Nucl Med 21:703-713, 1996
4. Zietman AL: When should radiation therapy follow radical prostatectomy in the management of prostate cancer? Mayo Clin Proc 69:700-701, 1994
5. Lange PH, Lightner DJ, Medini E, et al: The effect of radiation therapy after radical prostatectomy in patients with elevated prostate specific antigen levels. J Urol 144:927-933, 1990
6. Link P, Freiha FS, Stamey TA: Adjuvant therapy in patients with detectable prostate-specific antigen following radical prostatectomy. J Urol 145:532-534, 1991
7. Partin AW, Pound CR, Clemens JQ, et al: Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years. Urol Clin North Am 20:713-725, 1993
8. Klein EA: Management of elevated PSA after radical prostatectomy. J Urol 149:349A, 1993 (abstr 544)
9. McCarthy JF, Catalona WJ, Hudson MA: Effect of radiation therapy on detectable serum prostate specific antigen following radical prostatectomy: Early versus delayed treatment. J Urol 151:1575-1578, 1994
10. Schild SE, Wong WW, Grado GL, et al: Radiotherapy for isolated increases in serum prostate-specific antigen levels after radical prostatectomy. Mayo Clin Proc 69:613-619, 1994
11. Wu JJ, King SC, Montana GS, et al: The efficacy of postprostatectomy radiotherapy in patients with an isolated elevation of serum prostate-specific antigen. Int J Radiat Oncol Biol Phys 32:317-323, 1995
12. Platt JF, Bree RL, Schwab RE: The accuracy of staging of carcinoma of the prostate. AJR Am J Roentgenol 149:315-318, 1987
13. Tempany CM, Zhou X, Zerhouni EA, et al: Staging of prostate cancer: Results of radiology diagnostic oncology group project comparison of three MR imaging techniques. Radiology 192:47-54, 1994